Treatment of uncomplicated multidrug-resistant falciparum malaria with artesunate-atovaquone-proguanil.
In an open-label trial carried out on the northwest border of Thailand, 1596 patients with uncomplicated multidrug-resistant falciparum malaria were randomly assigned to receive atovaquone-proguanil, atovaquone-proguanil-artesunate, or artesunate-mefloquine and were followed up for 42 days. All 3 re...
Main Authors: | van Vugt, M, Leonardi, E, Phaipun, L, Slight, T, Thway, K, Mcgready, R, Brockman, A, Villegas, L, Looareesuwan, S, White, N, Nosten, F |
---|---|
Formato: | Journal article |
Idioma: | English |
Publicado: |
2002
|
Títulos similares
-
Artesunate-atovaquone-proguanil rescue treatment of multidrug-resistant Plasmodium falciparum malaria in pregnancy: a preliminary report.
por: Mcgready, R, et al.
Publicado: (2003) -
Short report: no evidence of cardiotoxicity of atovaquone-proguanil alone or in combination with artesunate.
por: Gupta, R, et al.
Publicado: (2005) -
A randomized comparison of artesunate-atovaquone-proguanil versus quinine in treatment for uncomplicated falciparum malaria during pregnancy.
por: Mcgready, R, et al.
Publicado: (2005) -
Absence of an interaction between artesunate and atovaquone--proguanil.
por: van Vugt, M, et al.
Publicado: (1999) -
The pharmacokinetics of atovaquone and proguanil in pregnant women with acute falciparum malaria.
por: Mcgready, R, et al.
Publicado: (2003)